New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer’s Disease Models
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPPβ Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer’s Disease Models
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-21
Publisher
IOS Press
Online
2020-06-23
DOI
10.3233/jad-200381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
- (2018) Finn Peters et al. ACTA NEUROPATHOLOGICA
- Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer’s Disease
- (2018) Iryna Voytyuk et al. BIOLOGICAL PSYCHIATRY
- Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
- (2018) Kaichuan Zhu et al. BIOLOGICAL PSYCHIATRY
- Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice
- (2018) Angie C.A. Chiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
- (2018) Xiangyou Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
- (2018) Brian A Gordon et al. LANCET NEUROLOGY
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
- (2018) Judite R. M. Coimbra et al. Frontiers in Chemistry
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
- (2018) Ming-Hsuan Ou-Yang et al. Science Translational Medicine
- Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
- (2017) Charbel E-H. Moussa EXPERT OPINION ON INVESTIGATIONAL DRUGS
- BACE inhibition-dependent repair of Alzheimer’s pathophysiology
- (2017) Aylin D. Keskin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-Penetrating Peptides: From Basic Research to Clinics
- (2017) Giulia Guidotti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Role of BACE1 in Alzheimer’s synaptic function
- (2017) Brati Das et al. Translational Neurodegeneration
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
- (2016) Kathryn M. Munro et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Euthanasia using gaseous agents in laboratory rodents
- (2016) A M Valentim et al. LABORATORY ANIMALS
- PEP-FOLD3: fasterde novostructure prediction for linear peptides in solution and in complex
- (2016) Alexis Lamiable et al. NUCLEIC ACIDS RESEARCH
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- BACE1 Physiological Functions May Limit Its Use as Therapeutic Target for Alzheimer's Disease
- (2016) Soraia Barão et al. TRENDS IN NEUROSCIENCES
- Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
- (2016) Saoussen Ben Halima et al. Cell Reports
- BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
- (2016) Robert Vassar Journal of Sport and Health Science
- Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
- (2016) Riqiang Yan Translational Neurodegeneration
- Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression
- (2015) Latha Devi et al. Current Alzheimer Research
- Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice
- (2015) D. R. Thakker et al. JOURNAL OF NEUROSCIENCE
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
- (2015) Utpal Das et al. NATURE NEUROSCIENCE
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
- (2015) Sofie Stalmans et al. PLoS One
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
- (2014) Arun K. Ghosh et al. CHEMICAL SOCIETY REVIEWS
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
- (2014) Robert Vassar Alzheimers Research & Therapy
- Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments
- (2012) Monica Cagnin et al. BRAIN RESEARCH
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and ImmunogenicityIn VitroandIn Vivo
- (2011) Julia Suhorutsenko et al. BIOCONJUGATE CHEMISTRY
- DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
- (2010) Weihong Tu et al. CELL
- β-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice
- (2010) Wan-Pin Chang et al. FASEB JOURNAL
- A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates A Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
- (2010) H. Fukumoto et al. JOURNAL OF NEUROSCIENCE
- Excitotoxicity through Ca2+-permeable AMPA receptors requires Ca2+-dependent JNK activation
- (2010) M. Vieira et al. NEUROBIOLOGY OF DISEASE
- In vivo biodistribution and efficacy of peptide mediated delivery
- (2010) Peter Järver et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- Effect of RasGAP N2 Fragment–Derived Peptide on Tumor Growth in Mice
- (2009) David Michod et al. JNCI-Journal of the National Cancer Institute
- The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
- (2009) Dries Vercauteren et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now